- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Syngene International Ltd (SYNN)
Syngene International Ltd stock price live, this page displays NSE SYNN stock exchange data. View the SYNN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Syngene International Ltd real time stock price chart below.
What Is the Syngene International Ltd Stock Price Today?
The Syngene International Ltd stock price today is 655.25.
What Is the Stock Symbol for Syngene International Ltd?
The stock symbol for Syngene International Ltd is ""SYNN.""
What Stock Exchange Does Syngene International Ltd Trade On?
Syngene International Ltd is listed and trades on the NSE stock exchange.
Is Syngene International Ltd a Good Stock to Buy?
Determining whether Syngene International Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SYNN quote. (ISIN: INE398R01022)
What Is the Syngene International Ltd Stock Price Today?
The Syngene International Ltd stock price today is 655.25.
What Is the Stock Symbol for Syngene International Ltd?
The stock symbol for Syngene International Ltd is ""SYNN.""
What Stock Exchange Does Syngene International Ltd Trade On?
Syngene International Ltd is listed and trades on the NSE stock exchange.
Is Syngene International Ltd a Good Stock to Buy?
Determining whether Syngene International Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SYNN quote. (ISIN: INE398R01022)
655.25
-17.90(-2.66%)
Closed·
Fair Value
An estimate of a Syngene International Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
653.15
673.95
52 wk Range
598.55
960.00
SYNN Scorecard
Full Analysis
Trading at a high earnings multiple
SYNN is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Syngene International Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
653.15673.95
52 wk Range
598.55960.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.19%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.19%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
SYNN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Syngene International Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with low price volatility
- Syngene acquires first U.S. manufacturing facility
- Investing.com
- Syngene acquires first U.S. manufacturing facility
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Syngene International Ltd Company Profile
Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally. The company provides discovery chemistry services, such as synthetic and medicinal chemistry, library and peptide synthesis, biomolecular science, organic electronic materials, and computational and analytical chemistry; discovery biology services in the areas of recombinant DNA engineering, cell line development, hybridoma technology, sequencing, protein sciences, screening and assay biology, DMPK, in vivo pharmacology, toxicology, and biologicals; and chemical, formulation, analytical, and clinical development services. It provides lead generation, preclinical development, API, and drug product development services; and clinical trial management, pharmacokinetic analysis/bioanalytical studies, biometrics and clinical data management, central lab, regulatory, medical monitoring, pharmacovigilance, and medical writing services. In addition, the company offers chemistry, biology, safety assessment, computational, and data sciences for traditional small molecule therapeutics; biologics; and specialty modalities, such as peptides, oligonucleotides, antibody-drug conjugates, and targeted degradation/stabilization. It serves pharmaceutical, biotechnology, animal health, nutrition, consumer goods, agrochemical, performance and specialty materials, and other companies. The company has collaborations with Bristol-Myers Squibb, Baxter Inc., and Amgen Inc. The company was incorporated in 1993 and is headquartered in Bengaluru, India. Syngene International Limited is a subsidiary of Biocon Limited.
Compare SYNN to Peers and Sector
Metrics to compare | SYNN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSYNNPeersSector | |
|---|---|---|---|---|
P/E Ratio | 51.4x | 39.4x | −0.5x | |
PEG Ratio | −18.38 | 2.92 | 0.00 | |
Price/Book | 5.5x | 7.7x | 2.6x | |
Price / LTM Sales | 7.0x | 6.7x | 3.3x | |
Upside (Analyst Target) | 9.0% | 8.2% | 43.5% | |
Fair Value Upside | Unlock | −9.9% | 6.8% | Unlock |
Earnings
Latest Release
Jul 23, 2025
EPS / Forecast
2.11 / 1.59
Revenue / Forecast
8.75B / 8.40B
People Also Watch
FAQ
What Stock Exchange Does Syngene International Ltd Trade On?
Syngene International Ltd is listed and trades on the Bombay Stock Exchange stock exchange.
What Is the Stock Symbol for Syngene International Ltd?
The stock symbol for Syngene International Ltd is "SYNN."
What Is the Syngene International Ltd Market Cap?
As of today, Syngene International Ltd market cap is 260.83B.
What Is Syngene International Ltd's Earnings Per Share (TTM)?
The Syngene International Ltd EPS (TTM) is 12.61.
When Is the Next Syngene International Ltd Earnings Date?
Syngene International Ltd will release its next earnings report on 21 Oct 2025.
From a Technical Analysis Perspective, Is SYNN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Syngene International Ltd Stock Split?
Syngene International Ltd has split 1 times.
How Many Employees Does Syngene International Ltd Have?
Syngene International Ltd has 6533 employees.
What is the current trading status of Syngene International Ltd (SYNN)?
As of 09 Aug 2025, Syngene International Ltd (SYNN) is trading at a price of 655.25, with a previous close of 673.15. The stock has fluctuated within a day range of 653.15 to 673.95, while its 52-week range spans from 598.55 to 960.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.